Centogene
Dr. Cheng-Kai Huang is an experienced professional in the fields of biomedical sciences and technical support. Currently serving as International Technical Support at Vazyme Biotech since March 2022, Dr. Huang is responsible for the western European region, providing extensive pre- and post-sale technical expertise, troubleshooting, and market research. Previous roles include a PhD researcher at Medizinische Hochschule Hannover and a research assistant at National Taiwan University focused on lung development and stem cells. Dr. Huang began a career in the medical laboratory as a technologist at Shuang-Ho Hospital, executing diagnostic tests and maintaining quality assurance programs. Dr. Huang holds a PhD in Biomedical Sciences, an MS in Anatomy and Cell Biology, and a BS in Medical Laboratory Science and Biotechnology.
Previous companies
This person is not in any teams
This person is not in any offices
Centogene
2 followers
Centogene BV is a Germany-based company engaged in the rare disease market. It focuses on transforming clinical, genetic and biochemical data into medical solutions for patients, physicians and pharmaceutical companies. The Company provides the full spectrum of methods and technology for human genetics analysis. It develops a rare disease platform based on its real-world data repository with over 2.0 billion weighted data points from over 450, 000 patients representing around 115 different, which includes epidemiologic, phenotypic and genetic data that reflects a global population, as well as a biobank of patients' blood samples. In addition, it is active in the research and development products for human genetics. The Company operates in Germany and the United States.